Background/Aims: Nutrigenomics New Zealand has invested considerable effort researching the role of nutrient-gene interactions in human inflammatory bowel disease (IBD). This research has utilised a number of ‘omics' techniques, including proteomics and metabolomics. Methods: Mouse models of intestinal inflammation have been used to investigate the mechanisms underlying IBD and to test foods or food components for potential beneficial effects. Proteomics combining two-dimensional gel electrophoresis with liquid chromatography-mass spectrometry (LC-MS) analysis of peptides, and metabolomics using both gas chromatography-MS and LC-MS have been combined with transcriptomics and microbiome analyses to comprehensively assess samples derived from these models. Results: Across several independent studies, we have identified key proteins and metabolites which are involved in chronic inflammation. We have also identified food compounds such as polyphenols (green tea polyphenols or curcumin) and polyunsaturated fatty acids, or whole foods such as salmon and broccoli, that reduce inflammation by regulating the activity of these proteins and metabolites. Conclusions: Omics techniques, including proteomics and metabolomics, have deepened our insight into the mechanisms underlying intestinal inflammation, and how nutrient-gene interactions may influence these. However, challenges remain in dealing with the enormous quantity of data generated by these techniques, and in utilising these data to improve the outcome for people with IBD.

Keywords:
Systems biology, Il10ߝ/ߝ mice, Mdr1aߝ/ߝ mice, Liquid chromatography-mass spectrometry
1.
Fenech M, El-Sohemy A, Cahill L, Ferguson LR, French TA, Tai ES, Milner J, Koh WP, Xie L, Zucker M, Buckley M, Cosgrove L, Lockett T, Fung KY, Head R: Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice. J Nutrigenet Nutrigenomics 2011;4:69-89.
2.
Barnett MP, McNabb WC, Cookson AL, Zhu S, Davy M, Knoch B, Nones K, Hodgkinson AJ, Roy NC: Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol 2010;11:39.
3.
Knoch B, Barnett MP, McNabb WC, Zhu S, Park ZA, Khan A, Roy NC: Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis. Mol Nutr Food Res 2010;54(suppl 1):S62-S74.
4.
Barnett MP, Cooney JM, Dommels YE, Nones K, Brewster DT, Park Z, Butts CA, McNabb WC, Laing WA, Roy NC: Modulation of colonic inflammation in Mdr1a-/- mice by green tea polyphenols and their effects on the colon transcriptome and proteome. J Nutr Biochem 2013;24:1678-1690.
5.
Cooney JM, Barnett MP, Brewster D, Knoch B, McNabb WC, Laing WA, Roy NC: Proteomic analysis of colon tissue from interleukin-10 gene-deficient mice fed polyunsaturated fatty acids with comparison to transcriptomic analysis. J Proteome Res 2012;11:1065-1077.
6.
Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, Helsby NA, Ferguson LR, Rowan DD: Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. J Proteome Res 2010;9:1965-1975.
7.
Knoch B, Nones K, Barnett MP, McNabb WC, Roy NC: Diversity of caecal bacteria is altered in interleukin-10 gene-deficient mice before and after colitis onset and when fed polyunsaturated fatty acids. Microbiology 2010;156:3306-3316.
8.
Ellett S, Ferguson IR, Zhu S, Karunasinghe N, Marlow G, Hurley D, Lam WJ, Han DY, Ferguson LR: Foodomics to study efficacy of human dietary interventions; in Ferguson LR (ed): Nutrigenomics and Nutrigenetics in Functional Foods and Personalized Nutrition. Boca Raton, CRC Press, 2013, pp 269-280.
9.
Marlow G, Ellett S, Ferguson IR, Zhu S, Karunasinghe N, Jesuthasan AC, Han DY, Fraser AG, Ferguson LR: Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients. Hum Genomics 2013;7:24.
10.
Edmunds SJ, Roy NC, Love DR, Laing WA: Kiwifruit extracts inhibit cytokine production by lipopolysaccharide-activated macrophages, and intestinal epithelial cells isolated from IL10 gene deficient mice. Cell Immunol 2011;270:70-79.
11.
Edmunds SJ, Roy NC, Davy M, Cooney JM, Barnett MP, Zhu S, Park Z, Love DR, Laing WA: Effects of kiwifruit extracts on colonic gene and protein expression levels in IL-10 gene-deficient mice. Br J Nutr 2012;108:113-129.
12.
Anderson NL, Anderson NG: Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 1998;19:1853-1861.
13.
Nones K, Dommels YE, Martell S, Butts C, McNabb WC, Park ZA, Zhu S, Hedderley D, Barnett MP, Roy NC: The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br J Nutr 2009;101:169-181.
14.
Griffin JL, Vidal-Puig A: Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics 2008;34:1-5.
15.
Lee S, Dawson PA, Hewavitharana AK, Shaw PN, Markovich D: Disruption of NaS1 sulfate transport function in mice leads to enhanced acetaminophen-induced hepatotoxicity. Hepatology 2006;43:1241-1247.
16.
Court MH, Freytsis M, Wang X, Peter I, Guillemette C, Hazarika S, Duan SX, Greenblatt DJ, Lee WM; Acute Liver Failure Study Group: The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure. J Pharmacol Exp Ther 2013;345:297-307.
17.
Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK: Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 2009;106:14728-14733.
18.
Marques JV, Dalisay DS, Yang H, Lee C, Davin LB, Lewis NG: A multi-omics strategy resolves the elusive nature of alkaloids in Podophyllum species. Mol Biosyst 2014;10:2838-2849.
19.
Koulman A, Lane GA, Harrison SJ, Volmer DA: From differentiating metabolites to biomarkers. Anal Bioanal Chem 2009;394:663-670.
20.
Rifai N, Gillette MA, Carr SA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006;24:971-983.
21.
Barnett MPG, Young W, Otter DE, Roy NC: Metabolomics and gene expression analyses of the Il10 gene-deficient mouse model of IBD; in NuGO Week 2013. Freising-Weihenstephan, Wageningen Academic Publishers, 2013, p 81.
22.
Patti GJ, Tautenhahn R, Rinehart D, Cho K, Shriver LP, Manchester M, Nikolskiy I, Johnson CH, Mahieu NG, Siuzdak G: A view from above: cloud plots to visualize global metabolomic data. Anal Chem 2013;85:798-804.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.